Electrolytes Flashcards
Hyponatremia
Diagnosed by Na level of less than 135 mol/L
Severe hyponatremia: less than 120mmol/L
Hyponatremia is a primarily disorder of H20 homeostasis
Urine Na less than 20meqs/L is consistent with hypovolemic hyponatremia
Urine osmolality <100 mosmol/kg is suggestive of polydipsia
Urine osmolality >400momol/kg suggest of AVP excess
Hyponatremia + hyperkalemia = suggest adrenal insufficiency or hypoaldosteronism
Cause of pseudo hyponatremia: hyperlipidemia or hyperproteinemia
Serum Na decreases 1.4mM for every 100mg/dL increase in glucose
Treatment for acute hypovolemic hyponatremia : fluid resuscitation with 0.9NaCL
Treatment for chronic hyponatremia: more than 48 hours
Desmopressin
Hypervolemic Hypernatremia
- CHF
- Hepatic cirrhosis
- Nephrotic syndrome
Associated with moderate decrease in hyponatremia: 125-135mmol/L
However severe CHF or cirrhosis may present with Na <120mmol/L
Treatment: after load reduction, large volume paracenthesis, immunomodulatory therapy , Na restriction, diuretic therapy, H20 restriction
Vasopressin antagonist; tolvaptan, conivaptan ( cirrhosis and CHF)
Euvolemic Hyponatremia
SIADH: syndrome of inappropriate antiduretic hormone- most cases
Others:
Hypothyroidism
Secondary adrenal insufficiency (pituitary disease)
Treatment Treat underlying disorder H20 restriction to <1L/d cornerstone of therapy (ineffective of poorly tolerated) Alternatives: loop diuretics Salt tablets
Acute Symptomatic hyponatremia
-medical emergency
Polydipsia with associated cause
Risk: women in premenopausal
Polydipsia: associated with increase AVP
Drug: MDMA ,
Osmotic demyelination syndrome: such as central pontine myelinolysis
Na is corrected corrected >10-12mM within the first 24
Or >18 within with the first 48
Treatment for acute symptomatic hyponatremia
Hypertonic solution: increase Na 1-2mM/L to a total increase of 4-6mM
Na should be monitored 2-4 hours
Treatment for chronic hyponatremia
<10-12mM within the first 24/h
And <18 in 48 hours
Hypernatremia
Mostly hypervolemic
Iatrogenic; Na bicarbonate infusion
Treatment:
1. Hypotonic solution
Central DI: intranasal DDAVP
Nephrogenic DI: hydrochlorothiazide (12.5-50mg/dl)
Lithium associated nephrogenic DI: amiloride 2.5-10mg/d
Potassium: major intracellular cation
Extracellular K: <20% of total body content
Promote uptake by cells:
1. Insulin, B2 adrenergic agonist, alkalosis
Promote effluent by cells:
1. Acidosis, insulinopenia, acute hyperosmolality
TTKG: transtubular K gradient
Formula
K (urine) x OSM serum over K (serum) x OSM (urine)
Urinary K to creatinine ratio:: >13mmol/g creatinine ( >1.5mmol/mol creatinine)
Compatible with excessive K excretion
Central line correction should not be more than 20mmol/h
Expected TTKG value
<3 in the presence of hypokalemia
>7-8 in the presence of hyperkalemia